Transgene SA

09/14/2024 | Press release | Distributed by Public on 09/14/2024 03:11

Transgene and BioInvent’s Oncolytic Virus BT-001 Shows Promising Antitumor Activity in Ongoing Phase I/IIa Trial in Solid Tumors that Failed Previous Treatments